Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Genetic Deletion of P2Y2 Receptor Offers Long-Term (5 Months) Protection Against Lithium-Induced Polyuria, Natriuresis, Kaliuresis, and Collecting Duct Remodeling and Cell Proliferation.

Zhang Y, Riquier-Brison A, Liu T, Huang Y, Carlson NG, Peti-Peterdi J, Kishore BK.

Front Physiol. 2018 Dec 17;9:1765. doi: 10.3389/fphys.2018.01765. eCollection 2018.

2.

The office changes leading to sit-to-stand ergonomics.

Carlson NG, Schwartz A, Greenwell J, Casura G.

Work. 2018;61(4):501-507. doi: 10.3233/WOR-182820.

PMID:
30475779
3.

Genetic deletion of ADP-activated P2Y12 receptor ameliorates lithium-induced nephrogenic diabetes insipidus in mice.

Zhang Y, Hansson KM, Liu T, Magnell K, Huang Y, Carlson NG, Kishore BK.

Acta Physiol (Oxf). 2019 Feb;225(2):e13191. doi: 10.1111/apha.13191. Epub 2018 Oct 31.

PMID:
30257062
4.

Antibodies in Autoimmune Human Neurological Disease: Pathogenesis and Immunopathology.

Williams JP, Carlson NG, Greenlee JE.

Semin Neurol. 2018 Jun;38(3):267-277. doi: 10.1055/s-0038-1660501. Epub 2018 Jul 16. Review.

PMID:
30011408
5.

Prasugrel suppresses development of lithium-induced nephrogenic diabetes insipidus in mice.

Zhang Y, Peti-Peterdi J, Brandes AU, Riquier-Brison A, Carlson NG, Müller CE, Ecelbarger CM, Kishore BK.

Purinergic Signal. 2017 Jun;13(2):239-248. doi: 10.1007/s11302-017-9555-6. Epub 2017 Feb 23.

6.

Retinal nerve fiber layer sector-specific compromise in relapsing and remitting multiple sclerosis.

Loughran-Fjeldstad AS, Carlson NG, Husebye CD, Cook LJ, Rose JW.

eNeurologicalSci. 2015 Oct 9;1:30-37. doi: 10.1016/j.ensci.2015.09.004. eCollection 2015 Jun.

7.

Clopidogrel attenuates lithium-induced alterations in renal water and sodium channels/transporters in mice.

Zhang Y, Peti-Peterdi J, Heiney KM, Riquier-Brison A, Carlson NG, Müller CE, Ecelbarger CM, Kishore BK.

Purinergic Signal. 2015 Dec;11(4):507-18. doi: 10.1007/s11302-015-9469-0. Epub 2015 Sep 19.

8.

The role of the prostaglandin E2 receptors in vulnerability of oligodendrocyte precursor cells to death.

Carlson NG, Bellamkonda S, Schmidt L, Redd J, Huecksteadt T, Weber LM, Davis E, Wood B, Maruyama T, Rose JW.

J Neuroinflammation. 2015 May 23;12:101. doi: 10.1186/s12974-015-0323-7.

9.
10.

Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.

Kishore BK, Carlson NG, Ecelbarger CM, Kohan DE, Müller CE, Nelson RD, Peti-Peterdi J, Zhang Y.

Acta Physiol (Oxf). 2015 Jun;214(2):176-88. doi: 10.1111/apha.12507. Epub 2015 May 4. Review.

11.

P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.

Zhang Y, Peti-Peterdi J, Müller CE, Carlson NG, Baqi Y, Strasburg DL, Heiney KM, Villanueva K, Kohan DE, Kishore BK.

J Am Soc Nephrol. 2015 Dec;26(12):2978-87. doi: 10.1681/ASN.2014010118. Epub 2015 Apr 8.

12.

Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures.

Greenlee JE, Clawson SA, Hill KE, Wood B, Clardy SL, Tsunoda I, Jaskowski TD, Carlson NG.

J Neuroinflammation. 2014 Sep 17;11:160. doi: 10.1186/s12974-014-0160-0.

13.

Advances in the management of neurogenic detrusor overactivity in multiple sclerosis.

Yonnet GJ, Fjeldstad AS, Carlson NG, Rose JW.

Int J MS Care. 2013 Summer;15(2):66-72. doi: 10.7224/1537-2073.2012-031.

14.

Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis.

Sato F, Martinez NE, Shahid M, Rose JW, Carlson NG, Tsunoda I.

Am J Pathol. 2013 Nov;183(5):1390-1396. doi: 10.1016/j.ajpath.2013.07.006. Epub 2013 Oct 1.

15.

Optical coherence tomography as a biomarker in multiple sclerosis.

Fjeldstad AS, Carlson NG, Rose JW.

Expert Opin Med Diagn. 2012 Nov;6(6):593-604. doi: 10.1517/17530059.2012.719496. Epub 2012 Aug 23.

PMID:
23480840
16.

Vitamin D as a clinical biomarker in multiple sclerosis.

Carlson NG, Rose JW.

Expert Opin Med Diagn. 2013 May;7(3):231-42. doi: 10.1517/17530059.2013.772978. Epub 2013 Feb 19. Review.

PMID:
23480560
17.

Genetic deletion of the P2Y2 receptor offers significant resistance to development of lithium-induced polyuria accompanied by alterations in PGE2 signaling.

Zhang Y, Pop IL, Carlson NG, Kishore BK.

Am J Physiol Renal Physiol. 2012 Jan 1;302(1):F70-7. doi: 10.1152/ajprenal.00444.2011. Epub 2011 Oct 5.

18.

Clinical biomarkers in multiple sclerosis.

Rose JW, Carlson NG.

Expert Opin Med Diagn. 2011 May;5(3):213-26. doi: 10.1517/17530059.2011.562498. Epub 2011 Mar 29.

PMID:
23484499
19.

Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures.

Greenlee JE, Clawson SA, Hill KE, Wood BL, Tsunoda I, Carlson NG.

J Neuropathol Exp Neurol. 2010 Oct;69(10):997-1007. doi: 10.1097/NEN.0b013e3181f0c82b.

20.

Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death.

Carlson NG, Rojas MA, Redd JW, Tang P, Wood B, Hill KE, Rose JW.

J Neuroinflammation. 2010 Apr 13;7:25. doi: 10.1186/1742-2094-7-25.

21.

Antineuronal autoantibodies in paraneoplastic cerebellar degeneration associated with adenocarcinoma of the prostate.

Greenlee JE, Clawson SA, Hill KE, Dechet CB, Carlson NG.

J Neurol Sci. 2010 Apr 15;291(1-2):74-8. doi: 10.1016/j.jns.2009.12.019. Epub 2010 Jan 20.

PMID:
20089262
22.

Potential involvement of P2Y2 receptor in diuresis of postobstructive uropathy in rats.

Zhang Y, Kohan DE, Nelson RD, Carlson NG, Kishore BK.

Am J Physiol Renal Physiol. 2010 Mar;298(3):F634-42. doi: 10.1152/ajprenal.00382.2009. Epub 2009 Dec 9.

23.

Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics.

Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee JE.

J Neuroinflammation. 2009 Oct 29;6:31. doi: 10.1186/1742-2094-6-31.

24.

Long-term daclizumab therapy in relapsing-remitting multiple sclerosis.

Rojas MA, Carlson NG, Miller TL, Rose JW.

Ther Adv Neurol Disord. 2009 Sep;2(5):291-7. doi: 10.1177/1756285609337992.

25.

Monoclonal antibody treatments for multiple sclerosis.

Rose JW, Foley JF, Carlson NG.

Curr Treat Options Neurol. 2009 May;11(3):211-20.

PMID:
19364456
26.

P2Y(2) receptors and water transport in the kidney.

Kishore BK, Nelson RD, Miller RL, Carlson NG, Kohan DE.

Purinergic Signal. 2009 Dec;5(4):491-9. doi: 10.1007/s11302-009-9151-5. Epub 2009 Mar 25.

27.

Potential role of purinergic signaling in lithium-induced nephrogenic diabetes insipidus.

Zhang Y, Nelson RD, Carlson NG, Kamerath CD, Kohan DE, Kishore BK.

Am J Physiol Renal Physiol. 2009 May;296(5):F1194-201. doi: 10.1152/ajprenal.90774.2008. Epub 2009 Feb 25.

28.

Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor.

Carlson NG, Rojas MA, Black JD, Redd JW, Hille J, Hill KE, Rose JW.

J Neuroinflammation. 2009 Feb 17;6:5. doi: 10.1186/1742-2094-6-5.

29.

Potential role of purinergic signaling in urinary concentration in inner medulla: insights from P2Y2 receptor gene knockout mice.

Zhang Y, Sands JM, Kohan DE, Nelson RD, Martin CF, Carlson NG, Kamerath CD, Ge Y, Klein JD, Kishore BK.

Am J Physiol Renal Physiol. 2008 Dec;295(6):F1715-24. doi: 10.1152/ajprenal.90311.2008. Epub 2008 Oct 1.

30.

Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.

Rose JW, Burns JB, Bjorklund J, Klein J, Watt HE, Carlson NG.

Neurology. 2007 Aug 21;69(8):785-9.

PMID:
17709711
31.

Immunohistochemical evidence of inducible nitric oxide synthase and nitrotyrosine in a case of clinically isolated optic neuritis.

Tsoi VL, Hill KE, Carlson NG, Warner JE, Rose JW.

J Neuroophthalmol. 2006 Jun;26(2):87-94.

PMID:
16845306
32.

Antioxidants in multiple sclerosis: do they have a role in therapy?

Carlson NG, Rose JW.

CNS Drugs. 2006;20(6):433-41. Review.

PMID:
16734496
33.

The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis.

Carlson NG, Hill KE, Tsunoda I, Fujinami RS, Rose JW.

J Neuroimmunol. 2006 May;174(1-2):21-31. Epub 2006 Mar 3.

PMID:
16516308
34.

P2Y2 receptor-mediated release of prostaglandin E2 by IMCD is altered in hydrated and dehydrated rats: relevance to AVP-independent regulation of IMCD function.

Sun R, Carlson NG, Hemmert AC, Kishore BK.

Am J Physiol Renal Physiol. 2005 Sep;289(3):F585-92. Epub 2005 Apr 19.

35.

Treatment of multiple sclerosis with an anti-interleukin-2 receptor monoclonal antibody.

Rose JW, Watt HE, White AT, Carlson NG.

Ann Neurol. 2004 Dec;56(6):864-7.

PMID:
15499632
36.
37.

Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesion.

Rose JW, Hill KE, Watt HE, Carlson NG.

J Neuroimmunol. 2004 Apr;149(1-2):40-9.

PMID:
15020063
38.

P2Y2 receptor-stimulated release of prostaglandin E2 by rat inner medullary collecting duct preparations.

Welch BD, Carlson NG, Shi H, Myatt L, Kishore BK.

Am J Physiol Renal Physiol. 2003 Oct;285(4):F711-21. Epub 2003 Jun 10.

40.
41.
42.

RNA editing (Q/R site) and flop/flip splicing of AMPA receptor transcripts in young and old brains.

Carlson NG, Howard J, Gahring LC, Rogers SW.

Neurobiol Aging. 2000 Jul-Aug;21(4):599-606.

PMID:
10924778
43.

Alcohol blocks TNFalpha but not other cytokine-mediated neuroprotection to NMDA.

Gahring LC, Carlson NG, Wieggel WA, Howard J, Rogers SW.

Alcohol Clin Exp Res. 1999 Oct;23(10):1571-9.

PMID:
10549987
44.

Antibodies to glutamate receptors: a role in excitatory dysregulation of the central nervous system?

Twyman RE, Rogers SW, Gahring LC, Carlson NG, Donevan SD.

Adv Neurol. 1999;79:535-41. Review. No abstract available.

PMID:
10514841
45.

Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways.

Carlson NG, Wieggel WA, Chen J, Bacchi A, Rogers SW, Gahring LC.

J Immunol. 1999 Oct 1;163(7):3963-8.

46.

A model for a glutamate receptor agonist antibody-binding site.

McDonald S, Carlson NG, Gahring LC, Ely KR, Rogers SW.

J Mol Recognit. 1999 Jul-Aug;12(4):219-25.

PMID:
10440992
47.
48.

Nicotine blocks TNF-alpha-mediated neuroprotection to NMDA by an alpha-bungarotoxin-sensitive pathway.

Carlson NG, Bacchi A, Rogers SW, Gahring LC.

J Neurobiol. 1998 Apr;35(1):29-36.

49.
50.

Interleukin-1alpha in the brain is induced by audiogenic seizure.

Gahring LC, White HS, Skradski SL, Carlson NG, Rogers SW.

Neurobiol Dis. 1997;3(4):263-9.

PMID:
9173924

Supplemental Content

Loading ...
Support Center